0001225208-13-002612.txt : 20130131 0001225208-13-002612.hdr.sgml : 20130131 20130131165416 ACCESSION NUMBER: 0001225208-13-002612 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130131 FILED AS OF DATE: 20130131 DATE AS OF CHANGE: 20130131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANIELS BRIAN CENTRAL INDEX KEY: 0001428698 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 13563279 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 doc4.xml X0306 4 2013-01-31 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001428698 DANIELS BRIAN BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 SVP Global Dev & Med Affairs Common Stock, $0.10 par value 2013-01-31 4 S 0 12000.0000 36.2200 D 50010.0410 D The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.20 to $36.27, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. /s/ Robert J. Wollin, attorney-in-fact for Brian Daniels 2013-01-31